PROCESSES

Glucose influx via GLUT2 transporters, phosphorylation by glucokinase, increased ATP/ADP ratio, closure of KATP channels, membrane depolarization, calcium influx via voltage-gated Ca2+ channels, and exocytosis of insulin granules

What is the complete sequence of intracellular events leading to glucose-stimulated insulin secretion in pancreatic beta-cells?

Phosphorylation of glucose to glucose-6-phosphate by glucokinase

What is the rate-limiting enzymatic first step of glucose sensing and metabolism inside the pancreatic beta-cell?

Closure of ATP-sensitive potassium (KATP) channels in the beta-cell plasma membrane

What ionic event directly results from an elevated intracellular ATP-to-ADP ratio during glucose metabolism?

Depolarization of the beta-cell plasma membrane

What physiological change occurs immediately after closure of ATP-sensitive potassium channels?

Opening of voltage-dependent calcium channels causing rapid intracellular calcium influx

What membrane event is triggered by beta-cell membrane depolarization to drive insulin granule exocytosis?

Cleavage of proinsulin into equal molar amounts of C-peptide and active 51-amino acid insulin within Golgi secretory granules

What biochemical processing step occurs inside beta-cell secretory vesicles prior to exocytosis?

Amplification of glucose-dependent insulin secretion, suppression of glucagon release, slowing of gastric emptying, and enhancement of central satiety

What is the multi-organ mechanism of action of GLP-1 upon binding its G-protein coupled receptor?

Enhancement of glucose-dependent insulin release from pancreatic beta-cells in response to ingested carbohydrates

What is the primary physiological function of GIP secreted by gut K-cells?

Inhibition of the DPP-4 enzyme, preventing the degradation and inactivation of endogenous incretin hormones GLP-1 and GIP

What is the mechanism of action of DPP-4 inhibitors like Sitagliptin and Linagliptin?

Genetic predisposition, environmental trigger, islet autoimmunity with autoantibody formation, progressive immune-mediated destruction of beta-cells, loss of first-phase insulin secretion, and clinical overt diabetes

What is the sequential pathophysiological timeline in the natural history of Type 1 Diabetes Mellitus?

Autoimmune T-cell mediated destruction of pancreatic beta-cells resulting in absolute insulin deficiency

What is the primary cause and underlying pathophysiology of Type 1 Diabetes Mellitus?

Stage 1 Type 1 Diabetes

What stage of Type 1 Diabetes is characterized by two or more islet autoantibodies with normal blood glucose levels and no clinical symptoms?

Stage 2 Type 1 Diabetes

What stage of Type 1 Diabetes is characterized by two or more islet autoantibodies, dysglycemia, and no overt clinical symptoms?

Stage 3 Type 1 Diabetes

What stage of Type 1 Diabetes is characterized by islet autoimmunity and overt clinical hyperglycemia exceeding diagnostic thresholds with classic symptoms?

Approximately 85 to 90 percent destruction of functional pancreatic beta-cell mass

What extent of beta-cell loss is required before clinical hyperglycemia and overt symptoms of Type 1 Diabetes manifest?

Presence of genetic susceptibility loci like HLA-DR3/DR4 combined with environmental triggers like enteroviruses that induce islet cell neoantigen expression

What leads to the initiation of islet autoimmunity in genetically susceptible individuals?

Unchecked hepatic gluconeogenesis, glycogenolysis, impaired peripheral glucose uptake, accelerated lipolysis, and ketogenesis

What metabolic cascades are directly activated by absolute deficiency of insulin in Type 1 Diabetes?

Peripheral insulin resistance in muscle and fat combined with progressive relative beta-cell secretory defect and elevated hepatic glucose output

What is the core pathophysiological mechanism driving Type 2 Diabetes Mellitus?

Ectopic lipid accumulation in liver and skeletal muscle, elevated free fatty acids, and pro-inflammatory adipokines like TNF-alpha and IL-6 inhibiting insulin receptor substrate (IRS-1) signaling

What leads to the development of peripheral insulin resistance in obesity?

Increased hepatic gluconeogenesis and glycogenolysis due to insensitivity of the liver to basal circulating insulin

What is the primary cause of elevated fasting plasma glucose in Type 2 Diabetes?

Loss of early phase insulin secretion, blunted incretin effect, hyperglucagonemia, enhanced renal glucose reabsorption, and central brain insulin resistance

What systemic physiological defects comprise the Ominous Octet in T2DM pathophysiology?

Chronic secretory stress from compensatory hyperinsulinemia leading to glucolipotoxicity, ER stress, and progressive beta-cell apoptosis

What causes progressive beta-cell failure over time in Type 2 Diabetes?

Overactivity of lipoprotein lipase stripping triglycerides from VLDL, forming small dense LDL and lowering HDL-C stability

What is the pathophysiology behind the atherogenic lipid triad in insulin resistance?

Non-enzymatic glycation of capillary basement membranes, cross-linking of collagen, and accumulation of advanced glycation end-products (AGEs)

What leads to microvascular complications like retinopathy, nephropathy, and neuropathy in chronic hyperglycemia?

Absolute or relative insulin deficiency combined with counterregulatory hormone excess (glucagon, epinephrine, cortisol, GH) accelerating lipolysis and hepatic ketogenesis

What is the primary pathophysiology driving Diabetic Ketoacidosis (DKA)?

Activation of hormone-sensitive lipase in adipose tissue releasing free fatty acids that undergo hepatic mitochondrial beta-oxidation into acetoacetate and beta-hydroxybutyrate

What pathway generates ketone bodies during absolute insulin deficiency?

Accumulation of circulating ketoacids buffering systemic bicarbonate, resulting in a high-anion-gap metabolic acidosis

What cause leads to the development of metabolic acidosis in DKA?

Osmotic diuresis caused by severe glucosuria, leading to profound loss of water, sodium, potassium, phosphate, and magnesium

What is the mechanism causing severe dehydration and electrolyte depletion in DKA and HHS?

Compensatory hyperventilation (Kussmaul breathing) to blow off carbon dioxide and raise arterial pH

What physiological compensatory mechanism is triggered by severe metabolic acidosis in DKA?

Relative insulin deficiency sufficient to suppress lipolysis and ketogenesis but inadequate to prevent severe hyperglycemia, osmotic diuresis, and extreme dehydration

What is the underlying pathophysiology of Hyperglycemic Hyperosmolar State (HHS)?

Extreme serum hyperosmolality exceeding 320 mOsm/kg drawing water out of cerebral neurons, resulting in intracellular neuronal dehydration

What causes profound mental status changes, lethargy, and coma in HHS?

Rapid shifts in serum osmolality during fluid resuscitation causing water movement into cerebral cells

What causes cerebral edema, a major fatal complication during DKA treatment in children?

SGLT2 inhibitor therapy causing continued renal glucose clearance that blunts hyperglycemia while low insulin levels continue to drive ketogenesis

What leads to Euglycemic Diabetic Ketoacidosis?

Suppression of endogenous beta-cell insulin secretion when plasma glucose drops below 80 mg/dL

What is the body's first line regulatory defense against falling blood glucose?

Release of counterregulatory hormones glucagon (2nd line) and epinephrine (3rd line) to stimulate hepatic glycogenolysis and gluconeogenesis when glucose falls below 70 mg/dL

What is the body's second and third line defense mechanism against hypoglycemia?

Autonomic nervous system activation triggering adrenergic symptoms (tremors, palpitations, anxiety) and cholinergic symptoms (sweating, hunger, paresthesias) when glucose falls below 60 mg/dL

What mechanism produces physical warning symptoms during acute hypoglycemia?

Failure of brain glucose transport when blood glucose drops below 50-55 mg/dL, causing confusion, slurred speech, drowsiness, and cognitive impairment

What causes neuroglycopenic symptoms during severe hypoglycemia?

Recurrent antecedent episodes of hypoglycemia blunting the sympathoadrenal response and shifting counterregulatory thresholds to lower glucose levels

What is the pathogenesis of Hypoglycemia-Associated Autonomic Failure (HAAF)?

Attenuated sympathetic neural and adrenomedullary epinephrine responses, leading to loss of warning adrenergic symptoms

What leads to the clinical phenomenon of hypoglycemia unawareness in long-standing diabetes?

A 2 to 3 week period of scrupulous avoidance of hypoglycemia to reset central neurogenic setpoints

What process reverses Hypoglycemia-Associated Autonomic Failure and restores symptom awareness?

Nocturnal hypoglycemia triggering a surge of counterregulatory epinephrine and glucagon, causing rebound morning hyperglycemia

What is the pathophysiological mechanism of the Somogyi phenomenon?

Nocturnal surge of growth hormone and increased insulin clearance during early morning hours, causing morning hyperglycemia without preceding hypoglycemia

What is the pathophysiological mechanism of the Dawn phenomenon?

Overproduction of incompletely processed Big IGF-II by non-pancreatic tumors binding insulin and IGF-1 receptors to suppress hepatic glucose output and drive muscle glucose uptake

What is the mechanism of Non-Islet Cell Tumor Hypoglycemia (NICTH)?

Autonomous, unregulated secretion of insulin by a pancreatic beta-cell adenoma despite falling plasma glucose levels

What is the underlying pathophysiology of an Insulinoma?

Expression of the SRY gene on the Y chromosome inducing bipotential gonadal differentiation into testes containing Sertoli and Leydig cells

What is the first step of male gonadal sex determination in embryogenesis?

Secretion of Anti-Mullerian Hormone (AMH) by fetal Sertoli cells causing regression of Mullerian ducts, and testosterone secretion by Leydig cells preserving Wolffian ducts

What hormonal mechanism directs male internal reproductive duct differentiation?

Conversion of testosterone into dihydrotestosterone (DHT) by 5-alpha-reductase in target tissue anlagen

What is the required hormonal step for male external genital differentiation between 4 and 12 weeks gestation?

Absence of SRY gene activity resulting in default gonadal differentiation into ovaries, regression of Wolffian ducts, preservation of Mullerian ducts, and female external genitalia

What is the physiological pathway of female sexual differentiation?

21-hydroxylase deficiency blocking cortisol synthesis, causing elevated ACTH that drives massive adrenal precursor conversion into androgen excess and virilization of 46XX female external genitalia

What is the detailed pathophysiology of Congenital Adrenal Hyperplasia?

Deficiency of syncytiotrophoblast aromatase preventing conversion of fetal adrenal androgen precursors into estrogens, causing accumulation of DHEA and testosterone that virilizes both 46XX fetus and mother

What is the pathogenesis of placental aromatase deficiency?

Inability to convert testosterone to DHT in target tissues, leading to a 46XY phenotype with normal testes, absent Mullerian structures, but ambiguous or female-appearing external genitalia

What is the mechanism of 5-alpha-reductase deficiency?

Loss-of-function mutations in the X-linked androgen receptor gene causing complete resistance to circulating androgens in a 46XY individual

What is the molecular pathogenesis of Complete Androgen Insensitivity Syndrome (CAIS)?

Failure of normal testicular descent into the scrotum due to mechanical obstruction, abnormal gubernaculum development, or impaired gonadotropin signaling

What is the cause and mechanism of cryptorchidism?

Secretion of placental hormones (hPL, progesterone, estrogen, cortisol) in late pregnancy (20-36 weeks AOG) causing maternal peripheral insulin resistance

What is the primary cause of gestational diabetes mellitus?

Directing maternal glucose away from maternal tissues to ensure continuous, adequate glucose transfer across the placenta to the growing fetus

What is the physiological purpose of gestational maternal insulin resistance?

Inability of maternal pancreatic beta-cells to increase insulin secretion by 200-300 percent to compensate for pregnancy-induced insulin resistance

What leads to the onset of clinical Gestational Diabetes Mellitus?

Maternal hyperglycemia causing fetal hyperglycemia, which triggers fetal pancreatic beta-cell hyperplasia, hyperinsulinemia, and accelerated fat deposition (macrosomia)

What is the Pedersen hypothesis explaining fetal macrosomia in GDM?

Abrupt loss of high maternal glucose transfer after umbilical cord clamping while fetal hyperinsulinemia persists, causing rapid glucose clearance

What causes neonatal hypoglycemia immediately following delivery in infants of diabetic mothers?

Fetal hyperinsulinemia suppressing surfactant synthesis by type II pneumocytes, predisposing newborn infants to respiratory distress syndrome

What causes neonatal respiratory distress syndrome in offspring of mothers with poorly controlled diabetes?

Chronic positive energy balance driven by genetic, environmental, and behavioral factors resulting in adipocyte hypertrophy and hyperplasia

What is the fundamental cause of obesity?

Adipocyte hypertrophy leading to local hypoxia, cell necrosis, macrophage infiltration, and release of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1)

What leads to systemic low-grade chronic inflammation in expanded adipose tissue?

High circulating leptin levels failing to suppress appetite or stimulate energy expenditure due to central leptin receptor signaling defects in the hypothalamus

What is the mechanism of leptin resistance in diet-induced obesity?

Adipose tissue expansion causing down-regulation of adiponectin transcription, reducing AMPK activation and insulin sensitivity in muscle and liver

What leads to reduced circulating adiponectin levels in obesity?

An autosomal dominant deletion of an imprinted region on paternal chromosome 15 (q11-q13) causing severe hypotonia, hyperphagia, and early-onset obesity

What is the genetic mechanism causing Prader-Willi Syndrome?

Heterozygous loss-of-function mutations in the MC4R gene impairing central anorexigenic signaling in the paraventricular nucleus

What is the most common monogenic cause of severe human obesity?

Pro-inflammatory cytokines and free fatty acids accumulating in hepatocytes, driving hepatic steatosis, oxidative stress, and non-alcoholic steatohepatitis (MASLD/MASH)

What leads to metabolic dysfunction-associated steatotic liver disease in pediatric obesity?

Infiltration of ApoB-containing LDL particles into the subendothelial space, oxidative modification, macrophage uptake forming foam cells, fatty streak formation, smooth muscle migration, and fibrous cap formation

What is the step-by-step pathogenesis of atherosclerosis?

Oxidized LDL particles activating endothelial cells to express adhesion molecules (VCAM-1, ICAM-1) that attract circulating monocytes into the vessel wall

What triggers monocyte recruitment in early atherogenesis?

Internalization of oxidized LDL by macrophage scavenger receptors (SR-A, CD36) without feedback inhibition, leading to engorgement with cholesterol esters

What process converts subendothelial macrophages into atherogenic foam cells?

Rupture or erosion of a thin fibrous cap exposing necrotic core tissue factor to blood, triggering immediate platelet aggregation and thrombosis

What causes acute myocardial infarction or ischemic stroke in established coronary plaques?

Loss-of-function mutations in the hepatic LDL receptor gene (LDLR) preventing endocytosis and clearance of circulating LDL, causing severe hypercholesterolemia

What is the genetic pathogenesis of Familial Hypercholesterolemia?

Gain-of-function mutations in the PCSK9 gene enhancing degradation of hepatic LDL receptors, resulting in high plasma LDL levels

What is the mechanism of PCSK9-mediated familial hypercholesterolemia?

Defects in apolipoprotein B-100 (APOB) reducing binding affinity for the hepatic LDL receptor, impairing clearance

What is the molecular mechanism of Familial Defective Apolipoprotein B-100?

Deficiency of endothelial lipoprotein lipase or apolipoprotein C-II preventing breakdown of chylomicrons, resulting in massive hypertriglyceridemia

What causes Familial Chylomicronemia Syndrome?

Extreme plasma triglyceride levels exceeding 500-1000 mg/dL generating toxic free fatty acids via pancreatic lipase that damage acinar cells and capillary endothelium

What is the mechanism by which severe hypertriglyceridemia causes acute pancreatitis?

Activation of AMP-activated protein kinase (AMPK) in the liver, leading to reduced hepatic gluconeogenesis and improved peripheral insulin sensitivity

What is the primary mechanism of action of Metformin?

Binding to and closing ATP-sensitive potassium (KATP) channels on beta-cells, causing membrane depolarization, calcium influx, and insulin exocytosis

What is the mechanism of action of Sulfonylureas like Gliclazide and Glimepiride?

Inhibition of the sodium-glucose cotransporter 2 (SGLT2) in the renal proximal convoluted tubule, blocking glucose reabsorption and inducing glycosuria

What is the mechanism of action of SGLT2 inhibitors like Empagliflozin and Dapagliflozin?

Agonism of GLP-1 receptors, stimulating glucose-dependent insulin release, suppressing glucagon, slowing gastric emptying, and enhancing central satiety

What is the mechanism of action of GLP-1 receptor agonists like Semaglutide and Liraglutide?

Agonism of nuclear PPAR-gamma receptors, regulating gene transcription to increase insulin sensitivity in adipose tissue, muscle, and liver

What is the mechanism of action of Thiazolidinediones like Pioglitazone?

Inhibition of competitive HMG-CoA reductase in hepatocytes, depleting intracellular cholesterol and upregulating surface LDL receptors to clear circulating LDL

What is the mechanism of action of Statins like Atorvastatin and Rosuvastatin?

Inhibition of the Niemann-Pick C1-Like 1 (NPC1L1) transporter at the intestinal brush border, blocking dietary and biliary cholesterol absorption

What is the mechanism of action of Ezetimibe?

Binding and neutralisation of circulating PCSK9 protein, preventing hepatic LDL receptor degradation and recycling receptors back to the cell membrane

What is the mechanism of action of PCSK9 inhibitor monoclonal antibodies like Evolocumab?

Small interfering RNA (siRNA) silencing hepatic PCSK9 gene expression, reducing PCSK9 protein synthesis and lowering plasma LDL

What is the mechanism of action of Inclisiran?

Agonism of nuclear PPAR-alpha receptors, upregulating endothelial lipoprotein lipase activity and ApoA-I/ApoA-II synthesis to lower triglycerides

What is the mechanism of action of Fibrates like Fenofibrate?

Reversible inhibition of gastric and pancreatic lipases in the lumen of the gastrointestinal tract, reducing dietary fat absorption by 30 percent

What is the mechanism of action of Orlistat?

Competitive blockade of mineralocorticoid receptors and androgen receptors, plus inhibition of 17-hydroxylase and 17,20-lyase enzymes

What is the mechanism of action of Spironolactone as an anti-androgen?

Competitive binding to androgen receptors and suppression of pituitary gonadotropins via progestogenic activity

What is the mechanism of action of Cyproterone Acetate?

Continuous stimulation of pituitary GnRH receptors causing receptor desensitization and down-regulation, suppressing LH/FSH secretion and gonadal steroidogenesis

What is the mechanism of action of GnRH agonists like Leuprolide?

Exogenous activation of nuclear androgen receptors, promoting protein synthesis, bone density, erythrocyte production, and male secondary sexual characteristics

What is the mechanism of action of exogenous Testosterone therapy?

Exogenous activation of nuclear estrogen receptors alpha and beta, regulating gene expression to induce female secondary sexual characteristics and fat redistribution

What is the mechanism of action of exogenous Estradiol therapy?

Opening of beta-cell ATP-sensitive potassium channels, hyperpolarizing the plasma membrane and inhibiting insulin exocytosis

What is the mechanism of action of Diazoxide in treating hyperinsulinemic hypoglycemia?

Binding to somatostatin receptors on pancreatic islet cells, suppressing secretagogue-stimulated insulin and glucagon release

What is the mechanism of action of Octreotide?

Increasing plasma osmolality to draw fluid out of swollen cerebral tissue into the vascular space, reducing intracranial pressure

What is the mechanism of action of IV Mannitol in treating DKA-related cerebral edema?

Binding to glucocorticoid receptors to regulate gene expression, promoting hepatic gluconeogenesis, lipolysis, and anti-inflammatory responses

What is the mechanism of action of Hydrocortisone?

Binding to mineralocorticoid receptors in renal distal tubules to promote sodium reabsorption and potassium/hydrogen excretion

What is the mechanism of action of Fludrocortisone?

Binding to hepatic glucagon receptors to activate adenylate cyclase and glycogen phosphorylase, stimulating glycogenolysis and gluconeogenesis

What is the mechanism of action of parenteral Glucagon in acute hypoglycemia?

Central stimulation of hypothalamic norepinephrine release, activating anorexigenic signaling to suppress appetite

What is the mechanism of action of Phentermine in weight management?

Exogenous testosterone stimulating erythropoietin production and bone marrow erythropoiesis while suppressing hepcidin

What causes erythrocytosis in transmen undergoing testosterone therapy?

High-dose estrogen therapy upregulating hepatic synthesis of clotting factors II, VII, IX, X, and fibrinogen while decreasing antithrombin III

What causes increased thromboembolic risk in transwomen receiving exogenous estrogen?